Short answer
AdaptHealth Corp. (AHCO) filed an 8-K current report with the SEC on April 13, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure). $450M revolver, $325M initial term loan, and $325M delayed-draw capacity expand liquidity and acquisition financing.
AdaptHealth Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $450M revolver, $325M initial term loan, and $325M delayed-draw capacity expand liquidity and acquisition financing
- Initial term loan refinancing replaces prior credit agreement debt; delayed draws may refinance $325M of 6.125% 2028 Senior Notes
- Maturity extends to April 13, 2031, subject to a 91-day springing maturity tied to senior-note maturities
- Leverage covenant capped at 3.50x, temporarily 4.00x after certain acquisitions; interest coverage minimum 3.00x
- SOFR loan margin ranges 1.125%-2.000%, with substantially all assets securing the facility and customary restrictive covenants
Item 1.02 · Termination of a Material Definitive Agreement
- Prior Credit Agreement fully repaid on April 10, 2026
- Related commitments, guarantees, liens and security interests terminated
- Refinancing funded through borrowings under the new Credit Agreement
- Debt facility transition completed without disclosed change in overall borrowing purpose
Item 7.01 · Regulation FD Disclosure
- April 13, 2026 press release announced the Credit Agreement
- Exhibit 99.1 contains the agreement details and is furnished, not filed under Section 18
- Credit Agreement terms determine borrowing capacity, financing costs, maturity, and covenant obligations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AdaptHealth Corp. 8-K filings
Get the next AHCO 8-K as it lands
Follow AHCO for push alerts, or ask the research agent what this filing means.